Incorporating scientific, ethical and economic considerations into the design of clinical trials in the pharmaceutical industry: a sequential approach

DOI10.1080/03610928408828831zbMath0559.62091OpenAlexW2113198424MaRDI QIDQ5185882

Tze Leung Lai

Publication date: 1984

Published in: Communications in Statistics - Theory and Methods (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1080/03610928408828831

zbMATH Keywords

stopping criteriaconfidence sequencedrug administrationdesign of clinical trialsdata monitoring

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Sequential statistical analysis (62L10)

Related Items (7)

A Review of Bayesian Perspectives on Sample Size Derivation for Confirmatory Trials ⋮ Small sample confidence intervals for the difference,ratio and odds ratio of two success probabilities ⋮ Time-uniform, nonparametric, nonasymptotic confidence sequences ⋮ Sequential Tests for Noninferiority and Superiority ⋮ Repeated confidence intervals and prediction intervals using stochastic curtailment under fractional Brownian motion ⋮ Repeated Confidence Intervals Under Fractional Brownian Motion in Long-Term Clinical Trials ⋮ GROUP SEQUENTIAL PROCEDURES FOR REPEATED EVENTS DATA WITH FRAILTY

Cites Work

• Sequential medical trials
• Sequential medical trials involving paired data

This page was built for publication: Incorporating scientific, ethical and economic considerations into the design of clinical trials in the pharmaceutical industry: a sequential approach